Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...

At least 15,000 healthcare professionals across Vietnam will benefit from the “AI Opportunity for Healthcare Professionals” ...

Google has created the Consumer Health Advisory Panel, a group of external experts tasked with guiding the company’s development of health-focused technologies. According to a July 15 news release ...